Global retinal biologics market is expected to generate around USD 28,015 million by 2025, at a CAGR of 11.5% between 2019 and 2025. The worldwide escalation of ophthalmic disorders, due to aging, is the prime factor driving the retinal biologics market globally.
Retinal Biologics Market
The report covers a forecast and an analysis of the global retinal biologics market on a global and regional level. The study provides historical data from 2017 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes the drivers and restraints of the global retinal biologics market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the global retinal biologics market on a global level.
In order to give the users a comprehensive view of the global retinal biologics market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new launch, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.
The study provides a decisive view of the global retinal biologics market is segmented based on drug class, indication, distribution channel, and region. The regional segment includes North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa.
Some key players of the retinal biologics market are Janssen Biotech, Alimera Sciences, F. Hoffmann-La Roche, Ocular Therapeutix, Genzyme Corporation, UCBCares, AbbVie, Allergan, Swedish Orphan Biovitrum, Genentech, Bristol-Myers Squibb, and Bausch & Lomb.
This report segments the global retinal biologics market into:
Global Retinal Biologics Market: Drug Class Analysis
Global Retinal Biologics Market: Indication Analysis
Global Retinal Biologics Market: Distribution Channel Analysis
Global Retinal Biologics Market: Regional Analysis